Imatinib-Responsive Hypereosinophilia in a Patient with B Cell ALL

Jamie Robyn, Pierre Noël, Iwona Włodarska, Mamta Choksi, Patricia O’Neal, Diane C. Arthur, Cynthia E. Dunbar, Thomas B. Nutman, Amy D. Klion

Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 16 citations · 29 references

Concepts

Abstract

Hypereosinophilia is a rare presenting sign of acute lymphocytic leukemia. A 29-year-old male was diagnosed with idiopathic hypereosinophilic syndrome with respiratory symptoms. Although his peripheral blood eosinophilia decreased in response to treatment with imatinib mesylate, a follow-up bone marrow showed a diffuse infiltrate of myeloperoxidase-negative blasts. He was subsequently diagnosed with CD10 positive precursor B lymphoblastic leukemia. This case underscores the importance of follow-up bone marrow examination in patients who demonstrate imatinib mesylate-responsive eosinophilia.

References

29